ESG Material Issues Assessment
Focused on What Matters Most
To identify and assess the ESG issues, responsibilities, risks and opportunities that are most important to our business, Elanco is committed to regular engagement with customers, non-governmental organizations (NGOs), suppliers, academia, investors, industry organizations, community groups, employees and other stakeholders. Our interactions with these groups directly influence our internal policies and practices, and inform our Healthy Purpose objectives and public disclosures. We further monitor emerging ESG issues and current events on an ongoing basis and prioritize efforts on matters applicable to Elanco, as appropriate.
We conducted our first formal ESG materiality assessment in 2020, led by a cross-functional internal team with external support. We expect to refresh our ESG materiality assessment in the next year, to ensure our ESG priorities and initiatives evolve with business developments, changes to stakeholder expectations and forthcoming disclosure regulations.
Additional detail on our managerial approach to material ESG topics is available in our collection of ESG Issue Briefs.
Healthier Animals
Topic | Explanation |
| Animal Health & Disease | The health of all animals including farm animals, pets and animals used in trials, inclusive of managing the disease. |
| Animal Research | The responsible use of animals in research. |
| Animal Welfare | The ethical and humane treatment of animals, notably in a pharmaceutical trial setting. |
| Quality of Animal Diet | The food and nutrition being fed to animals both in a farm 'feed' context and as well as pet food. |
| Responsible Pet Ownership | The importance and value of the overall care of a pet by its owner. |
Healthier People
Topic | Explanation |
| Access & Affordability | The ability of veterinarians, farmers and pet owners to access veterinary medicine products. |
| Antimicrobial Stewardship | Identification of the challenges related to the overuse of and declining efficacy of antibiotics. Also includes the promotion of responsible use of antibiotics. |
| Community Relations | The engagement of a business with local communities that explicitly seeks to create shared value. |
| Farmer Livelihoods | The welfare of farmers and their ability to generate sustainable incomes. |
| Human-Animal Bond | The benefits to people and pets of living together or having pets around. |
| Public Health | Activity that promotes and creates awareness of the general well-being of populations and illness prevention/cure. |
| Resilient Food Systems | A system of food production that is both sustainable and capable of delivering the food needed to prevent hunger. |
| Veterinarian Livelihoods | The welfare of veterinarians and their ability to generate sustainable incomes. |
Healthier Planet
Topic | Explanation |
| Air Pollution | Emissions into the air that have impacts are usually through particulate emissions. |
| Biodiversity and Wildlife | The flora and fauna that make up the living elements of the planet include land, sea, lakes and rivers. |
| Climate Change (GHG, Energy) | The response to climate change through specific methodologies. The issues caused by the overproduction of GHGs that lead to climate change. |
| Natural Resource Use | The general consideration is given to the extraction of resources from nature and their replenishment or not, e.g. deforestation. |
| Packaging | Packaging as a design challenge and associated waste and emissions concerns. |
| Pharmaceuticals in the Environment (PIE) | The risk of potential damage caused by pharmaceuticals being released into the environment. |
| Plastics | Plastic as a material and associated waste and emissions concerns. |
| Waste | All waste topics, including physical and hazardous waste. Plastics and packaging excluded. |
| Water | The use of water, limited localized availability of water and the pollution of water through farming or manufacturing processes. |
Healthier Enterprise
Topic | Explanation |
| Business Ethics | The application of ethics to a business, including compliance with legal regulations and company policies, anti-corruption efforts and management of third parties. |
| Consumer Trends & Shifts | The application of ethics to a business, including compliance with legal regulations and company policies, anti-corruption efforts and management of third parties. |
| Corporate Governance | The businesses' approach to management of all strategic risks and operational systems. Also includes stakeholder management. |
| Counterfeit Drugs | The potential for counterfeit products in the marketplace. |
| Diversity, Equity & Inclusion (DEI) | Diversity and inclusion policies and procedures that seek to promote inclusive working cultures. |
| Employee Health and Safety | The safety of workers and the protection of their physical and mental well-being. |
| Human Rights | The treatment of people, rooted in basic human rights, international law and local legislation. |
| Information Security | Security of all information assets within the company including cybersecurity and data privacy. |
| Innovation | The necessity of bringing innovation to customers and to the market. |
| Intellectual Property (IP) Rights | The protection of and ownership of intellectual property. |
| Labor Issues | The treatment of workers employed by the company often involving unions, matters of pay association. |
| Philanthropy | A company's charitable activities and the collaboration with partners to achieve philanthropic goals. |
| Product Quality & Safety | The consistent focus on producing high-quality products. |
| Responsible Marketing | The accurate and appropriate use of marketing that avoids confusion or harm. |
| Supply Chain | Management of third-party suppliers, including ethical conduct, quality and adherence to expected policies and procedures. |
| Talent Attraction and Retention | The recruiting, training and engagement efforts of all employees. |
| Transparency | The need or desire by stakeholders to see a higher level of disclosure from a business. |
| Research Trial Conduct | The policies and procedures governing R&D trials. |
About Elanco
Learn why we're a leading provider of innovative solutions that protect and enhance animal health.
Read About ElancoElanco's Healthy Purpose, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2022 Elanco or its affiliates.